Deepinder Goyal Announces USD 25 Million Expansion for ‘Continue Research’ Initiative
By Shishta Dutta | Published at: Oct 24, 2025 06:47 PM IST

New Delhi, October 24, 2025: Deepinder Goyal, CEO of Eternal, recently announced that he has made a personal investment of USD 25 million into his independent venture named Continue Research. The venture focuses on advancing studies in human health and longevity, and the investment will help the venture expand its operations.
The New Venture
Deepinder explained about the venture through a recent post on X. In the post, he explained that Continue Research is an initiative that aims at exploring the fundamental aspects of human aging and biology. The venture was launched two years ago and has a broader vision to extend the period of healthy human function. The initiative also aims to encourage society to think and act with a long-term perspective.
In his X post, Deepinder said, “Today, we are expanding Continue Research to include a USD 25 million fund (entirely personally backed) to support researchers across the world who dare to ask simpler questions than anyone else… Continue Research’s goal is to extend healthy human function long enough that humans stop making short-term decisions.”
Continue Research and Eternal
Goyal clarified that Continue Research operates independently and is not a part of Eternal’s business portfolio. Eternal manages businesses such as food delivery platform Zomato and quick commerce venture Blinkit. While independent of Eternal, the venture is a big step in Goyal’s ongoing commitment to fostering global research into human longevity and sustainable health innovation.
REF: [MEDIA=twitter]1981626460306637098[/MEDIA]
Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations

